Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors.
Ann N Y Acad Sci
; 777: 399-403, 1996 Jan 17.
Article
em En
| MEDLINE
| ID: mdl-8624120
ABSTRACT
CDP-choline was given to patients with Alzheimer's disease (AD) at a daily dose of 1000 mg/day p.o. for one month. This compound slightly improved mental performance, tended to reduce theta activity in fronto-temporal regions, increasing alpha power in occipital areas, and enhanced cerebrovascular perfusion by increasing blood flow velocity and reducing pulsatility and resistance indexes. In addition, CDP-choline diminished histamine and interleukin-1 levels in blood and serum, respectively, and increased plasma TNF.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Mapeamento Encefálico
/
Circulação Cerebrovascular
/
Cognição
/
Citidina Difosfato Colina
/
Doença de Alzheimer
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
1996
Tipo de documento:
Article